Qbic II

Qbic II is an early-stage venture capital fund based in Ghent, Belgium, managed by Qbic Fund. The fund specializes in investments in spin-off companies emerging from the universities of Ghent, Brussels, and Antwerp, as well as VITO. Qbic II focuses on sectors such as software, deeptech, biotech, and medtech, leveraging its strategic partnerships with these educational and research institutions to gain early access to promising projects. The fund employs a thorough review and analysis process to identify potential investments and provides hands-on support to the companies it backs. It is part of a broader initiative that has raised over €30 million, aimed at fostering innovation and growth in technology-linked startups.

Sofie Baeten

Co-Founder & Managing Partner

Steven Leuridan

Partner

Cedric Van Nevel

Investment Manager

Jean van Nuwenborg

Managing Partner

Martin De Prycker

Managing Partner

Sara Vandenwijngaert Ph.D

Junior Partner Qbic II & III

33 past transactions

Morrow Optics

Angel Round in 2022
Our view is a world where nothing is missed and one pair does it all. Because there’s more to see than ever before, and you deserve to see the bigger picture without edges or limitations. Our story starts with Jelle De Smet and Paul Marchal, two pioneers who with combined experience in electronics and nanotechnology invented the Autofocal lens. They saw a better way, where ageing eyesight is no longer a burden and progressive lenses were a prequel. And so Morrow was founded in 2016 — followed by years of research, development and meticulous fine-tuning. We now launch our flagship Autofocal Eyewear that combines Active Liquid Crystal and a two-layer corrective lens to transform your vision — both near and far — at the touch of a button. In our eyes, independence is a state of mind. It’s the unshackled freedom to do what you want and on your own terms, whilst always improving. Discover why there is always mor’ to see.

Swave Photonics

Seed Round in 2022
Swave Photonics operates as a fabless semiconductor company.

Aloxy

Venture Round in 2022
Aloxy nv develops and manufactures sensors to capture data from the field for processes in chemical industry. The company also provides a modular industrial Internet of Things (IoT) platform for accessing data; and it also allows users to directly integrate data with local systems on premise. It offers a solution for manual valve position indication and maintenance progress monitoring. Its device, consisting of inertial sensors, detects environmental temperature and atmospheric pressure; vibrations and movement; inclination and rotation; and magnetic fields. In addition, it allows for two-way interaction with local operators using buttons, multi-color light emitting diodes, and near-field-communication to locally communicate. Its sensors provide features, including geo-located using low-power localization technologies. Further, the company provides automated feedback loops based on asset location and workforce interaction; remote monitoring of the actual position of manual valves; and capturing real-time insights and automates processes. The company was founded in 2017 and is headquartered in Antwerp, Belgium.

Crowd Scan

Series A in 2021
Crowd Scan offers crowd density prediction services and integrated crowd management solutions. It designs a solution for measuring and analysing crowd density in real-time using a wireless sensor network.

Aphea.Bio

Series B in 2021
Aphea.Bio will develop next generation ‘biopesticides’ based on natural microorganisms. These products will provide an alternative for chemical pesticides, which are currently under serious pressure. In addition, the company will develop novel ‘biostimulants’, i.e. microorganisms that stimulate crop growth, for example through promoting the uptake of nutrients from the soil.

Abscint

Seed Round in 2021
ABSCINT engages in the development of radiolabelled single-domain antibodies for whole-body molecular imaging applications. Molecular imaging is used for the diagnosis of disease, the molecular characterization of a disease, monitoring treatment response, and the detection of disease recurrence.

Indigo Diabetes

Series B in 2020
Indigo Diabetes nv is a medical device company based in Ghent, Belgium, founded in 2016 by Danaë Delbeke and her team. The company specializes in developing an innovative invisible glucose monitor that utilizes advanced photonics technology to measure and manage blood glucose levels without the need for finger pricks. This high-tech sensor is designed to be inserted under the skin, allowing for continuous monitoring of blood sugar levels. Indigo Diabetes aims to enhance the user experience for individuals living with diabetes by providing a more accurate and convenient method for glucose monitoring, thereby transforming diabetes management.

QustomDot

Seed Round in 2020
QustomDot is a company based in Ghent, Belgium, that specializes in the development and manufacturing of on-chip grade and cadmium-free quantum dots. These tiny semiconductor nanoparticles are designed for color conversion, enabling the transformation of UV or blue light into a range of pure colors. QustomDot's products enhance the image quality of display screens used in various devices, including LED and LCD televisions, smartphones, smartwatches, and virtual or augmented reality goggles. In addition to its product offerings, the company assists customers in effectively integrating quantum dots into their technologies, thereby improving color gamut and energy efficiency. Founded in 2020, QustomDot is positioned at the forefront of advanced materials innovation.

MRM Health NV

Series A in 2020
MRM Health NV, is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome. MRM Health was incorporated early 2020 by MRM Technologies, a Center of Expertise for microbiome research based in the biotech cluster in Ghent, in a joint venture with the Flemish Institute of Biotechnology (VIB), an excellence-based entrepreneurial life sciences research institute in Flanders, Belgium, that focuses on translating basic scientific results into pharmaceutical, agricultural and industrial applications.

Calltic

Series A in 2020
Calltic develops fraud detection methods for telecom industry. It detects all on-net and off-net SIMboxes with one single tool. Calltic was founded in 2017 and is based in Gent, Belgium.

Biotalys

Series C in 2019
Biotalys is a green biotech company that employs its proprietary Agrobody technology platform to develop crop protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. It was incorporated in 2012 and is based in Ghent, Belgium.

Unifly

Series B in 2019
Unifly nv is an aviation software development company based in Antwerp, Belgium, specializing in drone traffic management and operations. Founded in 2015 by aerospace experts, Unifly has developed the UniflyUTMS, a cloud-based software platform designed to safely integrate unmanned aircraft systems into existing air traffic. This platform enables drone pilots to verify the legal status of their flights while allowing authorities to monitor and manage drone traffic effectively. The Unifly system is currently utilized by national authorities in Germany, Denmark, Austria, and Belgium, among others. The company is also active in the United States, where it is LAANC certified, and has implemented the first UTM system in Africa to support UNICEF's drone corridor in Malawi. Additionally, Unifly provides the technical UTM backbone for safe drone operations at the Fukushima Robot Test Field in Asia. As the drone industry continues to expand, Unifly plays a crucial role in ensuring the safe coexistence of drones and manned aviation through collaboration and innovative solutions.

Blue Foot Membranes

Seed Round in 2017
Blue Foot Membranes is a start-up company, producing and commercializing the unique and worldwide-patented Integrated Permeate Channel (IPC™) technology used in Membrane Bioreactors for the treatment of Industrial and Municipal waste water. BFM manufactures and supplies membranes for more efficient treatment of Industrial and Municipal waste water. The company was established in 2017 at Lommel, Limburg.

Sentiance

Series A in 2017
Sentiance is a data science company that specializes in transforming IoT sensor data into valuable insights regarding human behavior and real-time context. By leveraging motion data, Sentiance generates contextual insights that enable personalized engagement in areas such as mobility and wellbeing. The company employs behavioral change techniques to foster safer and more sustainable experiences. Sentiance collaborates with leading organizations to develop intelligent contextual recommenders, facilitating the creation of tailored services and products. This approach aims to empower users, allowing them greater control over their data while enhancing engagement in a human-centric economy.

Aphea.Bio

Series A in 2017
Aphea.Bio will develop next generation ‘biopesticides’ based on natural microorganisms. These products will provide an alternative for chemical pesticides, which are currently under serious pressure. In addition, the company will develop novel ‘biostimulants’, i.e. microorganisms that stimulate crop growth, for example through promoting the uptake of nutrients from the soil.

PharmaFluidics

Venture Round in 2017
Pharmafluidics is a spin-off company of the Vrije Universiteit Brussel, aiming at developing integrated milli- to nano-engineered solutions for mixing, separation and reaction processes. Rooted in chemical engineering with an advanced know-how in micro-fabrication technology, our team specializes in developing high quality and tailor-made solutions for any problem in the chemical and life sciences industry potentially benefiting from miniaturization or fine material structuring.

Indigo Diabetes

Series A in 2016
Indigo Diabetes nv is a medical device company based in Ghent, Belgium, founded in 2016 by Danaë Delbeke and her team. The company specializes in developing an innovative invisible glucose monitor that utilizes advanced photonics technology to measure and manage blood glucose levels without the need for finger pricks. This high-tech sensor is designed to be inserted under the skin, allowing for continuous monitoring of blood sugar levels. Indigo Diabetes aims to enhance the user experience for individuals living with diabetes by providing a more accurate and convenient method for glucose monitoring, thereby transforming diabetes management.

Morrow Optics

Seed Round in 2016
Our view is a world where nothing is missed and one pair does it all. Because there’s more to see than ever before, and you deserve to see the bigger picture without edges or limitations. Our story starts with Jelle De Smet and Paul Marchal, two pioneers who with combined experience in electronics and nanotechnology invented the Autofocal lens. They saw a better way, where ageing eyesight is no longer a burden and progressive lenses were a prequel. And so Morrow was founded in 2016 — followed by years of research, development and meticulous fine-tuning. We now launch our flagship Autofocal Eyewear that combines Active Liquid Crystal and a two-layer corrective lens to transform your vision — both near and far — at the touch of a button. In our eyes, independence is a state of mind. It’s the unshackled freedom to do what you want and on your own terms, whilst always improving. Discover why there is always mor’ to see.

Smartnodes

Seed Round in 2016
SmartNodes S.A., founded in 2014 and based in Liege, Belgium, specializes in providing advanced lighting systems and solutions for urban environments. The company offers a range of products, including the smart lighting system (SLS-G3), which features a node unit and power unit, as well as an access point system and smart lighting control unit. SmartNodes also provides innovative solutions for security, mobility, and environmental monitoring, aimed at enhancing urban safety and reducing light pollution. Their intelligent modules allow for adaptive lighting, which minimizes energy consumption by adjusting light levels based on the presence of road users, thus ensuring safety and visual comfort while significantly decreasing power usage and the ecological footprint of public lighting. Serving both public authorities and the private sector, SmartNodes operates as a subsidiary of Lacroix SA.

Sentiance

Seed Round in 2015
Sentiance is a data science company that specializes in transforming IoT sensor data into valuable insights regarding human behavior and real-time context. By leveraging motion data, Sentiance generates contextual insights that enable personalized engagement in areas such as mobility and wellbeing. The company employs behavioral change techniques to foster safer and more sustainable experiences. Sentiance collaborates with leading organizations to develop intelligent contextual recommenders, facilitating the creation of tailored services and products. This approach aims to empower users, allowing them greater control over their data while enhancing engagement in a human-centric economy.

Ovizio

Venture Round in 2015
Ovizio Imaging Systems NV/SA specializes in the development of digital holographic interferometric microscopy products, creating advanced 4D microscopic imaging devices and software. Founded in 2009 and headquartered in Brussels, Belgium, the company offers a range of devices, including the oLine 4D, which requires no specific sample preparation and compensates for sample imperfections; the iLine 4D, designed for various applications such as flow monitoring and cell culture observation; and various specialized instruments like ILine F for real-time monitoring of suspension cell cultures and iLine M for assessing cell confluence in multi-layer vessels. Ovizio also provides OsOne software for the visualization, analysis, and archiving of captured images, alongside QMod, which integrates holographic and fluorescence microscopy. Its products are widely utilized by scientists in pharmaceutical and biotechnology research and development, facilitating advancements in automated cell culture monitoring and analysis.

Ubidata

Venture Round in 2015
Ubidata SA/NV provides fleet management and vehicle tracking solutions in Belgium, The Netherlands, France, and Luxemburg. It develops and commercializes software and hardware solutions for the fleet and logistic industry. Its solutions include UBITrailer, a solution for trailers that manage and trace the truck trailers; UBIWagon, management and tracking solution for railway traffic; and UBILogistic, a mobile logistic solution. It also provides a multilingual PDA solution with software to help drivers in tracking parcels in real-time and automate the mobile logistic tasks; and UBIFleet, a real time tracking and tracing solution for truck tractors or light vehicles. The company serves the fleet and logistic industry. Ubidata SA/NV was founded in 2003 and is based in Brussels, Belgium.

Mind4Energy

Venture Round in 2015
Mind4Energy bvba, founded in 2011 by a group of four engineers in Ghent, Belgium, specializes in the design, commissioning, and testing of solar photovoltaic (PV) plants and systems. The company provides a range of engineering and monitoring services, including daily oversight of PV systems, on-site diagnostics, and annual inspections with detailed reports and recommendations. Additionally, Mind4Energy offers various products such as the Mind4Energy Datalogger, which integrates an industrial power supply with communication capabilities, as well as mobile tools like pyranometers and PV park analyzers. Committed to delivering high-quality services in the renewable energy sector, Mind4Energy aims to address the critical challenge of ensuring a reliable and sustainable energy supply.

Unifly

Seed Round in 2015
Unifly nv is an aviation software development company based in Antwerp, Belgium, specializing in drone traffic management and operations. Founded in 2015 by aerospace experts, Unifly has developed the UniflyUTMS, a cloud-based software platform designed to safely integrate unmanned aircraft systems into existing air traffic. This platform enables drone pilots to verify the legal status of their flights while allowing authorities to monitor and manage drone traffic effectively. The Unifly system is currently utilized by national authorities in Germany, Denmark, Austria, and Belgium, among others. The company is also active in the United States, where it is LAANC certified, and has implemented the first UTM system in Africa to support UNICEF's drone corridor in Malawi. Additionally, Unifly provides the technical UTM backbone for safe drone operations at the Fukushima Robot Test Field in Asia. As the drone industry continues to expand, Unifly plays a crucial role in ensuring the safe coexistence of drones and manned aviation through collaboration and innovative solutions.

CoScale

Venture Round in 2015
CoScale NV provides software solutions for IT operations analytics. It offers integrated platform to monitor full stack of containerized applications. It also provides COSCALE Application Performance Analyzer software that gathers and correlates data from Web applications and the underlying infrastructure to automatically identify and isolate disruptions, inefficiencies, and failures in Web applications; and enable organizations to optimize its infrastructure. The company offers its product as a subscription and licensing model for organizations operating in areas, such as e-commerce, online banking, online customer service, etc. CoScale NV was founded in 2013 and is based in Ghent, Belgium.

Confo Therapeutics

Venture Round in 2015
Confo Therapeutics is a drug discovery company based in Brussels, Belgium, founded in 2015. The company specializes in developing internal drug discovery programs focused on G-protein coupled receptors (GPCRs) to address unmet medical needs. Utilizing its proprietary CONFO® technology, Confo Therapeutics stabilizes inherently unstable functional conformations of GPCRs, providing a robust starting point for drug discovery. This approach reveals previously inaccessible structural features of these receptors, facilitating the identification of novel agonists that enhance therapeutic interventions.

Sentiance

Seed Round in 2015
Sentiance is a data science company that specializes in transforming IoT sensor data into valuable insights regarding human behavior and real-time context. By leveraging motion data, Sentiance generates contextual insights that enable personalized engagement in areas such as mobility and wellbeing. The company employs behavioral change techniques to foster safer and more sustainable experiences. Sentiance collaborates with leading organizations to develop intelligent contextual recommenders, facilitating the creation of tailored services and products. This approach aims to empower users, allowing them greater control over their data while enhancing engagement in a human-centric economy.

Biogazelle

Venture Round in 2014
At Biogazelle, we are dedicated to accelerate the understanding of the transcriptome through excellence in science and technology. We are convinced that unravelling the coding and non-coding regions of the genome will help researchers, clinicians, plant breeders, and other actors of the scientific community to get better answers to their questions. It is our mission to offer customized RNA gene expression services by selecting the best analytical platforms and by developing data-analysis software tools.

PharmaFluidics

Venture Round in 2014
Pharmafluidics is a spin-off company of the Vrije Universiteit Brussel, aiming at developing integrated milli- to nano-engineered solutions for mixing, separation and reaction processes. Rooted in chemical engineering with an advanced know-how in micro-fabrication technology, our team specializes in developing high quality and tailor-made solutions for any problem in the chemical and life sciences industry potentially benefiting from miniaturization or fine material structuring.

Track4C

Venture Round in 2014
Track4C Founded in 2012 and lead by an experienced management team with extensive experience in telecoms and other diverse fields. Track4C is supported by a network of business incubators, including iMinds, The University of Ghent, IWT (Agency for innovation by science and technology) and several other Flemish government initiatives. Significant funding has come from leading venture capital firms in Belgium, including Qbiq, PMV and iMinds.

CoScale

Seed Round in 2014
CoScale NV provides software solutions for IT operations analytics. It offers integrated platform to monitor full stack of containerized applications. It also provides COSCALE Application Performance Analyzer software that gathers and correlates data from Web applications and the underlying infrastructure to automatically identify and isolate disruptions, inefficiencies, and failures in Web applications; and enable organizations to optimize its infrastructure. The company offers its product as a subscription and licensing model for organizations operating in areas, such as e-commerce, online banking, online customer service, etc. CoScale NV was founded in 2013 and is based in Ghent, Belgium.

Multiplicom

Venture Round in 2013
Multiplicom N.V. is a Belgian company specializing in the development of molecular diagnostic test kits aimed at gathering genetic information for personalized treatment. Founded in 2010 and headquartered in Niel, Belgium, with an additional office in Lyon, France, the company provides a range of diagnostic assays across human, oncology, and prenatal applications. Its human application segment includes products for cancer, genetic, and cardiac disorders, such as various BRCA assays and tests for conditions like Marfan syndrome and cystic fibrosis. In the oncology segment, Multiplicom offers assays for molecular tumor pathology and cancer genetics. The prenatal application features the Clarigo product, which screens for chromosome abnormalities. The company operates a MASTR facility in Niel and an informatics facility in Gent, Belgium. Since January 2017, Multiplicom has functioned as a subsidiary of Agilent Technologies, Inc.